In the current protocol we will perform a variety of sensory tests of the skin and measure the pain response of patients and healthy volunteers. The aim of the study is (1) observational, i.e., to assess and describe the responses of patients and…
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
chronische pijn
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Pain scores in response to a heat stimulus
Secondary outcome
None
Background summary
Activation of nociceptors (pain sensors) at peripheral sites leads to
trafficking of afferent sensory information to the brain where pain is
perceived as an unpleasant sensation or feeling. The afferent sensory
information undergoes complex modulation at various points of its trajectory,
both at the spinal cord and at higher centers. Modulation at spinal sites is
related to the intrinsic response properties of primary afferent neurons within
the dorsal horn. For example, the response of warm fibers during a 39 oC
stimulus is completely suppressed by cooling pulses greater than 1 oC below 39
oC [1]. Another example is that upon noxious heat stimulation nociceptive
fibers (C- and type IIA-fibers) demonstrate a similar response with an early
peak frequency of discharge at the beginning of the stimulus followed by a slow
adapting response towards low frequency rates at 5 seconds after the onset of
the stimulus [2,3]. Central modulation of pain responses occurs via descending
pathways originating at higher centers in the CNS including the prefrontal
cortex, rostral anterior cingulate cortex (rACC) and insula, which project to
the periaquaductal gray, and rostral ventromedial medulla in the brainstem and
modulate nociceptive input at the level of the dorsal horn [4-6]. The
neurotransmitter involved in this process is noradrenaline that activate the
postsynaptic α2 adrenergic receptor in the dorsal horn. Activation of this
receptor causes profound analgesic responses. Expressions of endogenously
modulated pain responses are placebo- and stress-induced analgesia and
conditioning pain modulation (CPM) [7,8].
We previously tested the paradigm of offset analgesia where a disproportional
large amount of analgesia becomes apparent upon a slight decrease in noxious
heat stimulation, in both healthy volunteers and neuropathic pain patients
[9,10]. This test was abnormal or absent in neuropathic pain patients and
suggests a malfunction of the modulatory process in pain perception, at spinal
or supraspinal sites. Offset analgesia (see below, Fig 2A) is a very short test
that gives valuable information but that does not allow discrimination between
peripheral or central sites. Furthermore, due to its short temporal profile, no
information is obtained of longer stimulation of sensory neurons.
Study objective
In the current protocol we will perform a variety of sensory tests of the skin
and measure the pain response of patients and healthy volunteers. The aim of
the study is (1) observational, i.e., to assess and describe the responses of
patients and volunteers to a variety of different stimulation paradigms; (2)
diagnostic, i.e., to assess whether specific tests are possibly diagnostic for
specific pain syndromes; (3) mechanistic, i.e., whether the results of the test
may give us valuable information on the site of modulation (central or
peripheral). The latter is possible by applying specific pharmacological agents
and observed possible changes in the response to the pain stimuli.
The following populations will be studied:
1. Healthy volunteers;
2. Neuropathic pain patients due to (a) Complex Regional Pain Syndrome, (b)
Diabetic neuropathy, (c) Sarcoidosis, (d) Ischemic events in spinal cord or
brain; (e) Fibromyalgia.
Study design
Open
Study burden and risks
None
Albinusdreef 2
2333 ZA Leiden
NL
Albinusdreef 2
2333 ZA Leiden
NL
Listed location countries
Age
Inclusion criteria
Patient inclusion criteria. (i) Patients diagnosed with CRPS-1, small-fiber neuropathy, central neuropathic pain or fibromyalgia, according to the guidelines of the IASP or other professional pain societies (eg., Netherlands Society of Anesthesiologists); (ii) a pain score of 5 or higher; (iii) age between 18 and 75 years; (iv) being able to give written informed consent.;Volunteer inclusion criteria. Healthy volunteers in the age range 18-75 years of either sex.
Exclusion criteria
Patient and volunteer exclusion criteria. (i) Unable to give written informed consent; (ii) medical disease such as renal, liver, cardiac, vascular (incl. hypertension) infectious disease; (iii) increased intracranial pressure; (iv) epilepsy; (v) psychosis; (vi) glaucoma; (vii) a history of cerebro-vascular accident < 1 year; (viii) pregnancy; and (ix) obesity (BMI > 30).
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL39757.058.12 |